Patent · US Expired

Peroral dosage form for peptide containing medicaments, in particular insulin

US6468959B1 · kind B1 · utility

24Cited by
8References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 5, 1994
Grant dateOct 22, 2002
Priority date
Expiry dateApr 5, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/4891
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a plural dosage form for peptide pharmaceuticals comprising a matrix of gelatin or gelatin derivative having distributed therein the peptide pharmaceutical in particular insulin, as well as, pharmaceutically conventional carriers and additives. By selection of the appropriate gelatin the pharmaceutical is liberated in the small intestine or the large intestine so that is not enzymatically degraded anymore by peptidases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.